Close

Rachel Mercaldo

Bio

Education

Affiliations

Preferred Pronouns

Prefer not to disclose

Personal Academic Website

Topics of Interest/Expertise
 

Countries of Work/Collaboration

United States

Projects

Papers

Lipner EM, Powell C, Nelson S, Fintzi JR, French JP, Mercaldo RA, Falkinham JO 3rd., Rebecca Prevots D. (2025). The risk of NTM pulmonary infection associated with trace metal exposure from public distribution system water in the United States. Journal of exposure science & environmental epidemiology

Bents SJ, Powell C, French JP, Prevots DR, Mercaldo RA. (2025). Factors predicting incidence of nontuberculous mycobacteria in an era of climate change and altered ecosystems in the United States. The Science of the total environment, (999)

Marshall JE, Mercaldo RA, Lipner EM, Prevots DR. (2024). Correction: Nontuberculous mycobacteria testing and culture positivity in the United States. BMC infectious diseases, 24(1)

Marshall JE, Mercaldo RA, Lipner EM, Prevots DR. (2024). Nontuberculous mycobacteria testing and culture positivity in the United States. BMC infectious diseases, 24(1)

Bents SJ, Mercaldo RA, Powell C, Henkle E, Marras TK, Prevots DR. (2024). Nontuberculous mycobacterial pulmonary disease (NTM PD) incidence trends in the United States, 2010-2019. BMC infectious diseases, 24(1)

Mercaldo RA, Marshall JE, Cangelosi GA, Donohue M, Falkinham JO 3rd., Fierer N, French JP, Gebert MJ, Honda JR, Lipner EM, Marras TK, Morimoto K, Salfinger M, Stout J, Thomson R, Prevots DR. (2023). Environmental risk of nontuberculous mycobacterial infection: Strategies for advancing methodology. Tuberculosis (Edinburgh, Scotland), (139)

Marshall JE, Mercaldo RA, Lipner EM, Prevots DR. (2023). Incidence of nontuberculous mycobacteria infections among persons with cystic fibrosis in the United States (2010-2019). BMC infectious diseases, 23(1)

Lipner EM, French JP, Mercaldo RA, Nelson S, Zelazny AM, Marshall JE, Strong M, Falkinham JO 3rd., Prevots DR. (2023). The risk of pulmonary NTM infections and water-quality constituents among persons with cystic fibrosis in the United States, 2010-2019. Environmental epidemiology (Philadelphia, Pa.), 7(5)

Lipner EM, French JP, Nelson S, Falkinham Iii JO, Mercaldo RA, Blakney RA, Daida YG, Frankland TB, Messier KP, Honda JR, Honda S, Prevots DR. (2022). Vanadium in groundwater aquifers increases the risk of MAC pulmonary infection in O'ahu, Hawai'i. Environmental epidemiology (Philadelphia, Pa.), 6(5)

Mercaldo RA, Marshall JE, Prevots DR, Lipner EM, French JP. (2023). Detecting clusters of high nontuberculous mycobacteria infection risk for persons with cystic fibrosis - An analysis of U.S. counties. Tuberculosis (Edinburgh, Scotland), (138)

Marshall JE, Gebert MJ, Lipner EM, Salfinger M, Falkinham Iii JO, Prevots DR, Mercaldo RA. (2023). Methods of isolation and identification of nontuberculous mycobacteria from environmental samples: A scoping review. Tuberculosis (Edinburgh, Scotland), (138)

Lipner EM, French JP, Falkinham JO 3rd., Crooks JL, Mercaldo RA, Henkle E, Prevots DR. (2022). Nontuberculous Mycobacteria Infection Risk and Trace Metals in Surface Water: A Population-based Ecologic Epidemiologic Study in Oregon. Annals of the American Thoracic Society, 19(4)

Mercaldo R, Whalen C, Kakaire R, Nakkonde D, Handel A, Sekandi JN. (2021). Community drivers of tuberculosis diagnostic delay in Kampala, Uganda: a retrospective cohort study. BMC infectious diseases, 21(1)

Mercaldo RA, Bellan SE. (2019). Evaluation of alternative endpoints for ZIKV vaccine efficacy trials. Vaccine, 37(15)

If you’d like to update your profile, please email modifications to questions@midasnetwork.us.